Drug Innovation: a unique programme
The Dutch Master's Selection Guide (Keuzegids Masters 2017) ranked this programme as the best in the field of Chemistry in the Netherlands.
Drug Innovation is about:
- developing new drugs to combat drug-resistant microorganisms
- using gene or protein technologies to create therapies targeted at individual patients
- finding a way to imprint the immune system to increase tolerance
- exploring the relationship between gut microbes and brain disease
- learning how to use proteomics to study stem cell development
- reducing the side effects of treatment by finding new ways to deliver drugs directly onto the tumor
- updating and speeding up the drug regulatory process
The Master’s in Drug Innovation programme focuses on diagnostics and the improvement and management of small molecule and biomolecular drugs. Drug innovation covers many topics such as the development of new vaccines and the study of antibodies, gene therapeutics, and medical nutrition. Once developed, a new drug then needs to go through approval, which raises a whole new set of challenges, for example the establishment of new methods and criteria for evaluating the quality, efficacy, safety, and performance of the drug.
This broad, interdisciplinary programme is open to graduates from a wide range of disciplines such as chemistry, biology, pharmaceutical sciences, biomedical sciences, or medicine.
Many elective courses
Our programme offers a diverse suite of elective courses. This means you can concentrate on the topics of most interest to you. You will also take an internship with one of the research teams working on drug innovation at Utrecht University. This work may lead to publication in scientific journals within the field or new drug patents or protocols.
Graduates of this programme may go on to undertake research in drug innovation at universities, in the pharmaceutical or and biotechnology industry or to work in science or healthcare.